Abstract
In diabetic hypertensive rats, tempol reduces albuminuria by restoring the redox imbalance. Increased formation of reactive oxygen species leading to activation of poly(ADP-ribose) polymerase (PARP)-1 and podocyte loss by apoptosis contribute to albuminuria in diabetes mellitus (DM). In the present study, we investigated the hypothesis that in DM tempol reduces albuminuria by inhibition of PARP-induced podocyte apoptosis. DM was induced in 4-week-old spontaneously hypertensive rats by streptozotocin. Mouse and human podocyte cell lines were cultured in normal or high-glucose conditions, with or without tempol and/or a PARP-1 inhibitor, PJ34. In diabetic rats, tempol treatment did not affect plasma glucose levels or systolic blood pressure. Albuminuria was higher in diabetic rats, and it was reduced by tempol. DM leads to an elevation of glomerular apoptotic cells and to podocyte loss; both were prevented by tempol treatment. DM increases the expression of poly(ADP-ribose)-modified proteins in isolated glomeruli, and it was reduced by tempol. In vitro, high glucose increased caspase-3 activity and led to a higher number of apoptotic cells that were prevented by tempol and the PARP-1 inhibitor. In DM, tempol reduces albuminuria a...Continue Reading
References
Dec 1, 1988·Journal of Hypertension·M E CooperA E Doyle
Nov 7, 1999·Diabetologia·T W MeyerR G Nelson
Apr 30, 2002·Diabetes·Lilia A SilveiraJosé B Lopes De Faria
May 4, 2005·Cellular and Molecular Life Sciences : CMLS·K ErdélyiL Virág
May 28, 2005·Diabetes·Gunter WolfFuad N Ziyadeh
Dec 29, 2005·Diabetes·Katalin SusztakErwin P Böttinger
Oct 27, 2006·Diabetes·Csaba SzabóKatalin Suszták
Aug 2, 2007·Nature Reviews. Drug Discovery·Csaba SzabóRafael Radi
Sep 1, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Alexandros PapadimitriouShanta J Persaud
Sep 29, 2007·Diabetologia·S MeniniG Pugliese
Mar 12, 2008·Basic & Clinical Pharmacology & Toxicology·Paola Yam-CanulJosé Pedraza-Chaverri
Jun 7, 2008·The American Journal of Pathology·Pal Pacher, Csaba Szabo
Oct 14, 2008·American Journal of Nephrology·Elisa B M I PeixotoJose B Lopes de Faria
Dec 30, 2008·Pharmacological Reviews·Christopher S Wilcox, Adam Pearlman
Feb 12, 2009·Diabetes·Assaad A EidHanna E Abboud
May 13, 2009·Current Opinion in Nephrology and Hypertension·Basil O BurneyGeorge L Bakris
Mar 26, 2010·Investigative Ophthalmology & Visual Science·Mariana A B RosalesJacqueline M Lopes de Faria
Jul 14, 2010·Biochimica Et Biophysica Acta·Hanna ShevalyeIrina G Obrosova
Jan 14, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·José Butori Lopes de FariaJacqueline Mendonça Lopes de Faria
Citations
Jul 30, 2014·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Michael P SarrasRobert V Intine
Oct 22, 2013·Free Radical Biology & Medicine·Justine M AbaisPin-Lan Li
Jul 6, 2014·TheScientificWorldJournal·Yi ChangThanasekaran Jayakumar
May 23, 2013·Biochemical and Biophysical Research Communications·Dong Il Kim, Soo Hyun Park
May 9, 2015·Apoptosis : an International Journal on Programmed Cell Death·Sun Ha LeeShin-Wook Kang
Feb 7, 2015·The Journal of Nutritional Biochemistry·E B PeixotoJ B Lopes de Faria
Feb 20, 2014·Journal of Korean Medical Science·Hye Eun YoonSeok Joon Shin
Jul 30, 2016·Journal of Renal Injury Prevention·Akram RanjbarFarhad Khoshjou
Feb 4, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Hengmei ZhuXiaojiang Zhan
Aug 10, 2021·Frontiers in Medicine·Jing XuDaisuke Koya